I take it that is for US approval. I know everyone thinks Pharmion will have a harder go at in Europe needing to wait for survival data, hopefully the drug makes it to market there without much delay as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.